Results

Total Results: 550 records

Showing results for "failures".

441. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/v1-breast-cancer-medications-for-risk-reduction--s
     May 06, 2002 - archived Evidence Summary Breast Cancer: Medications for Risk Reduction May 06, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and …

442. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index
     September 03, 2013 - archived Final Evidence Summary Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index September 03, 2013 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Res…

443. The Ankle–Brachial Index for PAD and CVD Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_Fp-7sDqohFNj_9WF3_tY
     September 01, 2013 - The Ankle–Brachial Index for PAD and CVD Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the USPSTF The Ankle–Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the U.S. Preventive Services Tas…

444. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index-2013
     September 03, 2013 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Evidence Summary Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index September 03, 2013 Recommendations made by the US…

445. Chemo and Couns/2nd instal (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
     July 01, 2002 - Chemo and Couns/2nd instal 33 Epidemiology Despite improvements in the rates of screening and early detection, treatment advances, and healthier lifestyles, breast cancer remains the most common non-skin cancer among women in the United States. In 2002, it will account for an estimated 203,500 new cases of invasiv…

446. PII: S0749-3797(01)00255-0 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
     January 01, 2001 - PII: S0749-3797(01)00255-0 Screening and Treating Adults for Lipid Disorders Michael P. Pignone, MD, MPH, Christopher J. Phillips, MD, MPH, David Atkins, MD, MPH, Steven M. Teutsch, MD, MPH, Cynthia D. Mulrow, MD, MSc, Kathleen N. Lohr, PhD Context: Screening and treatment of lipid disorders in people at high risk f…

447. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
     April 09, 2001 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 April 09, 2001 Recommendations made by the USPSTF are independent of the U.…

448. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Breast Cancer: Medications for Risk Reduction May 06, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They shoul…

449. High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-10/2023-annual-report-to-congress.pdf
     January 01, 2023 - High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress November 2021 High-Priority Evidence Gaps for Clinical Preventive Services SUBMITTED BY: Dr. Michael J. Barry, Chair Dr. Wanda K. Nicholson, Vice Chair Dr. Michael Silverstein, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE…

450. 11th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2021-uspstf-annual-report-to-congress.pdf
     January 01, 2021 - 11th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services High-Priority Evidence Gaps for Clinical Preventive Services 11TH ANNUAL REPORT TO CONGRESS SUBMITTED BY: Dr. Karina W. Davidson, Chair Dr. Carol M. Mangione, Vice Chair Dr. Michael J. Barry, Vice Chair ON BEH…

451. 12th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2022-annual-report-to-congress.pdf
     January 01, 2022 - 12th Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services November 2021 High-Priority Evidence Gaps for Clinical Preventive Services SUBMITTED BY: Dr. Carol M. Mangione, Chair Dr. Michael J. Barry, Vice Chair Dr. Wanda K. Nicholson, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE…

452. High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/2023-annual-report-to-congress.pdf
     January 01, 2023 - High-Priority Evidence Gaps for Clinical Preventive Services: 13th Annual Report to Congress November 2021 High-Priority Evidence Gaps for Clinical Preventive Services SUBMITTED BY: Dr. Michael J. Barry, Chair Dr. Wanda K. Nicholson, Vice Chair Dr. Michael Silverstein, Vice Chair ON BEHALF OF THE U.S. PREVENTIVE…

453. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
     September 01, 2005 - Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the U.S. Preventive Services Task Force Heidi D. Nelson, MD, MPH; La…

454. Zyao53-Sqrb6Ozzkzdmjjt (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
     December 01, 2003 - Obesity is an increasingly significant U.S. health problem. Over 4 decades, the prevalence of obesity (body mass index [BMI], kilograms of weight divided by height in meters squared [kg/m2], ≥ 30) has increased from 13% to 31% in adults and the prevalence of overweight (BMI 25–29.9 kg/m2) has increased from 31% to 34%.…

455. Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/vxPM4Bo9RXZGUDH6MWnDht
     May 01, 2013 - Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the USPSTF Screening for and Treatment of Suicide Risk Relevant to Primary Care: A Systematic Review for the U.S. Preventive Services Task Force Elizabeth O’Connor, PhD; Bradley N. Gaynes, MD, MPH; Brittany U. Burda, MPH; Cl…

456. Archived: Evidence Summary: Obesity in Adults: Screening and Counseling, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
     December 15, 2003 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Obesity in Adults: Screening and Counseling, 2003 December 15, 2003 Recommendations made by the USPSTF are independent of the U.S. government. They s…

457. Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/h8qcZeQ68AQPS9DemArgXX
     July 13, 2021 - Screening for Prediabetes and Type 2 Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (Reprinted) Clinical Review & Education JAMA | US Preventive Services Task Force | EVIDENCE REPORT Screening for Prediabetes and Type 2 Diabetes Updated Evidence Report and Syst…

458. Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qpv8h6ZMbYLYzakVrNQoj2
     October 11, 2022 - Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence and Systematic Review for the USPSTF Screening for Depression and Suicide Risk in Children and Adolescents Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Meera Viswanathan, PhD; Ina F. Wall…

459. Evidence Summary: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication September 28, 2021 Recommendations made by the USPSTF are independ…

460. Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary21/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling
     February 03, 2014 - Evidence Summary Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication February 03, 2014 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of H…